Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy

This study has been completed.

Study NCT00005779 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: June 3, 2000 Last Updated: August 7, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given